IMMUNOGLOBULINBINDENDE PROTEINE

European patent · EP3708667 · In force

Register entry

Publication number
EP3708667
Application number
EP18875049
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Nov 8, 2018
Published
Sep 16, 2020
Granted
Jan 1, 2025
Protection ends at the latest
Nov 7, 2038
Next annual fee due
Nov 30, 2026
IPC classes
C12N 15/31 (2006.01)
C07K 1/14 (2006.01)
C07K 1/22 (2006.01)
C07K 14/31 (2006.01)
C12N 1/21 (2006.01)
C12N 11/02 (2006.01)
C12P 21/02 (2006.01)
B01D 15/38 (2006.01)
Priority
JP 2017216028 09.11.2017
JP 2018043281 09.03.2018
JP 2018128287 05.07.2018
PCT application
PCT/JP2018/041551 08.11.2018
PCT publication
WO2019/093439 16.05.2019
Filing language
Japanese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 1, 2025

    Change

    Published in Swissreg on 01.12.2025

  2. Nov 12, 2025

    Change

    Published in Swissreg on 12.11.2025

  3. Jan 3, 2025

    Agent entered

    Representative
    Novagraaf International SA, Chemin de l'Echo 3, 1213 Onex

    Published in Swissreg on 03.01.2025

  4. Jan 1, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 01.01.2025

Parties

Holder

Tosoh Corporation

TOSOH CORPORATION

4560, Kaisei-cho, Shunan-shi, Yamaguchi 746-8501, JP

Agent

Novagraaf International SA

Chemin de l'Echo 3, 1213 Onex

Inventor

YAMANAKA, Naoki

Ayase-shi Kanagawa 252-1123, JP

UCHIDA, Yukie

Ayase-shi Kanagawa 252-1123, JP

TERAO, Yosuke

Ayase-shi Kanagawa 252-1123, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.